CRH
Corticoliberin
Also known as: CRF, CRF_HUMAN, CRH1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P06850
- Gene
- CRH
- Ensembl
- ENSG00000147571
- Chromosome
- 8
- Canonical length
- 196 aa
- Protein class
- Plasma proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a member of the corticotropin-releasing factor family. The encoded preproprotein is proteolytically processed to generate the mature neuropeptide hormone. In response to stress, this hormone is secreted by the paraventricular nucleus (PVN) of the hypothalamus, binds to corticotropin releasing hormone receptors and stimulates the release of adrenocorticotropic hormone from the pituitary gland. Marked reduction in this protein has been observed in association with Alzheimer's disease. Autosomal recessive hypothalamic corticotropin deficiency has multiple and potentially fatal metabolic consequences including hypoglycemia and hepatitis. In addition to production in the hypothalamus, this protein is also synthesized in peripheral tissues, such as T lymphocytes, and is highly expressed in the placenta. In the placenta it is a marker that determines the length of gestation and the timing of parturition and delivery. A rapid increase in circulating levels of the hormone occurs at the onset of parturition, suggesting that, in addition to its metabolic functions, this protein may act as a trigger for parturition. [provided by RefSeq, Nov 2015]
Canonical amino-acid sequenceUniProt
196 residues, UniProt reviewed canonical sequence.
>P06850|CRH
1 MRLPLLVSAG VLLVALLPCP PCRALLSRGP VPGARQAPQH PQPLDFFQPP PQSEQPQQPQ
61 ARPVLLRMGE EYFLRLGNLN KSPAAPLSPA SSLLAGGSGS RPSPEQATAN FFRVLLQQLL
121 LPRRSLDSPA ALAERGARNA LGGHQEAPER ERRSEEPPIS LDLTFHLLRE VLEMARAEQL
181 AQQAHSNRKL MEIIGKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CRH can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 53 nTPM
Expression across tissuesHPA
Tissue
- hypothalamus: 53 nTPM
- cerebral cortex: 13 nTPM
- amygdala: 6.7 nTPM
- placenta: 6.2 nTPM
- basal ganglia: 4.5 nTPM
- hippocampal formation: 4.4 nTPM
Single-cell type
- syncytiotrophoblasts: 250 nCPM
- pancreatic islet cells: 148 nCPM
- other brain neurons: 35 nCPM
- brain inhibitory neurons: 24 nCPM
- early spermatids: 19 nCPM
- late spermatids: 17 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- medulla oblongata: 318 nTPM
- thalamus: 50 nTPM
- pons: 39 nTPM
- hypothalamus: 22 nTPM
- midbrain: 20 nTPM
- cerebral cortex: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.72
- gnomAD pLI
- 0.72
- gnomAD missense Z
- 1.1
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adrenal gland development
- associative learning
- cellular response to cocaine
- cellular response to dexamethasone stimulus
- chemical synaptic transmission
- diterpenoid metabolic process
- female pregnancy
- glucocorticoid biosynthetic process
- hormone-mediated apoptotic signaling pathway
- hypothalamus development
- inflammatory response
- learning or memory
- locomotory exploration behavior
- long-term synaptic potentiation
- lung development
- monoatomic ion homeostasis
- negative regulation of circadian sleep/wake cycle, REM sleep
- negative regulation of epinephrine secretion
- negative regulation of gene expression
- negative regulation of glucagon secretion
- negative regulation of luteinizing hormone secretion
- negative regulation of norepinephrine secretion
- negative regulation of systemic arterial blood pressure
- neuron apoptotic process
- parturition
- positive regulation of behavioral fear response
- positive regulation of calcium ion import
- positive regulation of cAMP/PKA signal transduction
- positive regulation of cell population proliferation
- positive regulation of circadian sleep/wake cycle, wakefulness
- positive regulation of corticosterone secretion
- positive regulation of corticotropin secretion
- positive regulation of cortisol secretion
- positive regulation of gene expression
- positive regulation of insulin secretion involved in cellular response to glucose stimulus
- regulation of NMDA receptor activity
- regulation of serotonin secretion
- response to aldosterone
- response to corticosterone
- response to estrogen
- response to ethanol
- response to ether
- response to immobilization stress
- response to pain
- response to xenobiotic stimulus
- signal transduction
- synaptic transmission, dopaminergic
- positive regulation of digestive system process
Molecular functions
- corticotropin-releasing hormone receptor 1 binding
- corticotropin-releasing hormone receptor 2 binding
- hormone activity
- neuropeptide hormone activity
- signaling receptor binding
- corticotropin-releasing hormone activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CRH in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CRH as an antibody target. Whether an autoantibody or antibody against CRH could matter depends on whether native CRH is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CRH is annotated as secreted, so native CRH circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label CRH as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...